Revenue (Quarterly) Chart

View Revenue (Quarterly) for MCVEF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 744.60M
March 31, 2026 730.27M
December 31, 2025 711.98M
September 30, 2025 691.36M
June 30, 2025 676.33M
March 31, 2025 608.43M
December 31, 2024 592.87M
September 30, 2024 579.81M
June 30, 2024 548.39M
March 31, 2024 541.37M
December 31, 2023 496.74M
September 30, 2023 479.19M
June 30, 2023 462.22M
March 31, 2023 449.88M
December 31, 2022 405.42M
September 30, 2022 371.28M
June 30, 2022 386.00M
March 31, 2022 428.20M
December 31, 2021 430.12M
September 30, 2021 394.87M
June 30, 2021 420.64M
Date Value
March 31, 2021 382.06M
December 31, 2020 354.92M
September 30, 2020 306.62M
June 30, 2020 218.92M
March 31, 2020 263.08M
December 31, 2019 254.31M
September 30, 2019 235.82M
June 30, 2019 227.99M
March 31, 2019 226.75M
December 31, 2018 206.76M
September 30, 2018 194.71M
June 30, 2018 191.94M
March 31, 2018 198.98M
December 31, 2017 179.78M
September 30, 2017 169.16M
June 30, 2017 155.96M
March 31, 2017 151.13M
December 31, 2016 142.79M
September 30, 2016 138.51M
June 30, 2016 139.68M
March 31, 2016 129.10M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. 3.043B
Labcorp Holdings, Inc. 3.731B
OPKO Health, Inc. 163.58M
Psychemedics Corp. --
NeoGenomics, Inc. 201.66M